MICHELLE MAI: Open Payments
NPI 1891418562 · GREENWOOD VILLAGE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,699 in 100 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,225 · 2025 $2,699
Food & beverage: $2,634Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $581 |
| Galderma Laboratories, L.P. | 14 | $394 |
| GENZYME CORPORATION | 10 | $326 |
| Amgen Inc. | 8 | $265 |
| Regeneron Healthcare Solutions, Inc. | 7 | $251 |
| Janssen Biotech, Inc. | 7 | $206 |
| LEO Pharma Inc. | 8 | $184 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| UCB, Inc. | 3 | $106 |
| Arcutis Biotherapeutics, Inc. | 6 | $100 |
Products named: DUPIXENT, SKYRIZI, NEMLUVIO, OTEZLA, TREMFYA, RINVOQ, ADBRY, Bimzelx.
Industry payments across CO — which companies pay providers there.
